University Clinical Research Center
Welcome,         Profile    Billing    Logout  
 0 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Doumbia, Seydou
NCT04149106: Seasonal Malaria Chemoprevention With Dihydroartemisin Piperaquin vs. Sulfadoxine-pyrimethamin+Amodiaquin

Active, not recruiting
3
4556
RoW
Sulfadoxine pyrimethamine + Amodiaquin, SPAQ, Dihydroartemisinin piperaquin, DHAPQ
University Clinical Research Center, Mali, Tulane University, University of South Florida, University of Copenhagen, Deakin University, Johns Hopkins University
Malaria,Falciparum
12/22
12/23
NCT04149119: Attractive Targeted Sugar Bait Trial in Mali

Not yet recruiting
3
2100
RoW
Attractive Target Sugar Baits (ATSB)
University Clinical Research Center, Mali
Vector Transmission
12/23
06/24
NCT02876328 / 2019-001308-39: Partnership for Research on Ebola VACcinations

Completed
2
4789
RoW
Ad26.ZEBOV, rHAd26, MVA-BN-Filo, MVA, MVA-mBN226B, rVSVΔG-ZEBOV-GP, rVSV, V920, Placebo, rVSV boost
National Institute of Allergy and Infectious Diseases (NIAID), Partnership for Research on Ebola Virus in Liberia (PREVAIL), Institut National de la Santé Et de la Recherche Médicale, France, London School of Hygiene and Tropical Medicine, European and Developing Countries Clinical Trials Partnership (EDCTP)
Ebola Virus Disease
12/19
12/23
PPD-Mali, NCT05260879: Potential Effectiveness of the Diabetes Prevention Program in the Peri-urban Area of Bamako, Mali

Completed
N/A
440
RoW
Diabetes prevention program, PPD-Mali
University Clinical Research Center, Mali, Columbia University, Fogarty International Center of the National Institute of Health
Diabetes Mellitus, Type 2
06/22
04/23
NCT03783143: Prevalence and Incidence of Lassa Virus Infection in Southern Mali

Completed
N/A
4375
RoW
National Institute of Allergy and Infectious Diseases (NIAID)
Lassa Virus Infection
07/24
07/24

Download Options